Data on 566 patients with traumatic brain injuries revealed those who received erythropoiesis-stimulating agents were 75% less likely to die of the condition compared with those not given the red blood cell-producing agents. The findings appear in the journal Archives of Surgery.
Boosting red blood cells is linked to lower brain trauma mortality
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||